by Webdesign Squad | Mar 5, 2021 | Uncategorized
The Private Placement Financing was taken out for gross proceeds of €10.3 million, €8 million via convertible bonds (of which €4 million were received in December 2019). Affluent Medical has been granted two “PGE” (government-backed) loans for a total of €2.2 million...
by Webdesign Squad | Mar 5, 2021 | Uncategorized
Epygon is the first transcatheter mitral valve designed to restore the physiological blood flow vortex and treat left ventricle disease, in particular in so-called “functional” patients. No mitral valve prosthesis currently on the market or in development was designed...
by Webdesign Squad | Mar 5, 2021 | Uncategorized
KALIOS is the first fully adjustable mitral valve repair ring, designated for the percutaneous treatment of both residual and recurrent Mitral Regurgitation (MR). First patient implanted in Vienna General Hospital (AKH) Obtention of regulatory approval to start...
by Webdesign Squad | Mar 5, 2021 | Uncategorized
Michel Finance is appointed CEO.Executive team is strengthened with the appointment of:Daniele Zanotti (the former CEO) as Chief Technology and Innovation Officer leading technology developments and the execution of programs,Professor François Laborde as Chief...
by Webdesign Squad | Mar 5, 2021 | Uncategorized
Outstanding results from SCOPE 1 randomized, controlled, multicentric clinical trial, proving the efficacy of treating life-threatening Abdominal Aortic Aneurysm (AAA), by thrombogenic fibers embolization of the aneurysm sac when performing an EndoVascular Aneurysm...
Recent Comments